Paragon Private Wealth Management’s AbbVie ABBV Stock Holding History

Paragon Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.68M	Buy	10,654 +55	+0.5%	+$11.8K	0.7%	36
2026 Q1	$2.31M	Sell	10,599 -88	-0.8%	-$19.5K	0.72%	35
2025 Q4	$2.44M	Sell	10,687 -1,315	-11%	-$300K	0.75%	32
2025 Q3	$2.78M	Buy	12,002 +130	+1%	+$26.5K	0.91%	22
2025 Q2	$2.2M	Sell	11,872 -1,238	-9%	-$230K	0.88%	25
2025 Q1	$2.75M	Sell	13,110 -231	-2%	-$44.9K	1.28%	17
2024 Q4	$2.37M	Buy	13,341 +1,231	+10%	+$226K	1.09%	24
2024 Q3	$2.39M	Buy	12,110 +860	+8%	+$161K	1.19%	23
2024 Q2	$1.93M	Buy	11,250 +296	+3%	+$49K	1.09%	26
2024 Q1	$1.99M	Buy	10,954 +476	+5%	+$82K	1.19%	24
2023 Q4	$1.62M	Buy	10,478 +943	+10%	+$137K	1.13%	28
2023 Q3	$1.42M	Buy	9,535 +226	+2%	+$33.2K	1.17%	25
2023 Q2	$1.25M	Buy	9,309 +364	+4%	+$53.4K	1%	31
2023 Q1	$1.43M	Buy	8,945 +1,925	+27%	+$294K	1.2%	25
2022 Q4	$1.13M	Buy	7,020 +1,139	+19%	+$175K	1.02%	33
2022 Q3	$881K	Buy	5,881 +2,729	+87%	+$392K	0.86%	37
2022 Q2	$483K	Buy	+3,152	New	+$482K	0.51%	62

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Paragon Private Wealth Management's ABBV Position: Q2 2026 in Review

Paragon Private Wealth Management increased its AbbVie (ABBV) stake by 0.52% in Q2 2026, buying an estimated $11.8K and bringing the position to 10,654 shares worth $2.68M. The position accounts for 0.7% of the portfolio, ranked #36.

Paragon Private Wealth Management first reported a position in ABBV in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.78M in Q3 2025. 2,028 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Paragon Private Wealth Management held 10,654 shares of AbbVie worth $2.68M as of Q2 2026.
Paragon Private Wealth Management bought 55 AbbVie shares in Q2 2026, an estimated $11.8K.
AbbVie made up 0.7% of Paragon Private Wealth Management's portfolio in Q2 2026, its #36 holding.
Paragon Private Wealth Management first reported a position in AbbVie in Q2 2022 and has held it in 17 quarters since.
Paragon Private Wealth Management's AbbVie position peaked at $2.78M in Q3 2025.
2,028 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.